Translate AMICOR contents if you like

Thursday, July 26, 2018

BAN2401

Experimental Alzheimer’s Drug Significantly Slowed Patients’ Cognitive Decline

The surprising results have buoyed hopes for treatment
An investigational Alzheimer’s drug significantly slowed patients’ cognitive decline in a large clinical trial, unexpected and unprecedented results that could move the treatment’s makers to roll the dice on an early approval.
In the study, the highest-tested dose of a drug from Biogen and Eisai was markedly better than placebo at delaying the memory-destroying effects of Alzheimer’s. After 18 months, patients who got the drug, called BAN2401, performed 30 percent better on a cognitive test than those getting placebo./.../

No comments: